Can we measure effectiveness of new cystic fibrosis treatments in improving lung health in children with cystic fibrosis aged less than 2 years of age during clinical trials conducted for the approval of new medicines?
Objective airway artery dimensions compared to CT scoring methods assessing structural cystic fibrosis lung disease
